AdDRESSing T-cell responses to antituberculous drugs
Br J Dermatol
.
2017 Feb;176(2):292-293.
doi: 10.1111/bjd.15167.
Authors
R Pavlos
1
,
A Redwood
1
,
E Phillips
1
2
Affiliations
1
Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia.
2
Departments of Medicine, Pathology, Microbiology, Immunology and Pharmacology, Vanderbilt University Medical Center, Nashville, TN, U.S.A.
PMID:
28244076
PMCID:
PMC5429398
DOI:
10.1111/bjd.15167
No abstract available
Publication types
Comment
MeSH terms
Antitubercular Agents / therapeutic use*
Humans
Mycobacterium tuberculosis
T-Lymphocytes*
Substances
Antitubercular Agents
Grants and funding
P30 AI110527/AI/NIAID NIH HHS/United States
P50 GM115305/GM/NIGMS NIH HHS/United States
R01 AI103348/AI/NIAID NIH HHS/United States